Paul Ginocchio

Paul Ginocchio, listed as finance chief, appears in our data through filings on Augmedix, Inc. shares, published by SEC (Form 4). In total, 11 filings cover trades dated from 19 May 2021 to 2 October 2024.

Purchases make up the whole of the open-market record (8 purchases, €365k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 option exercises.

The median purchase comes to €39k. 4 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 4 October 2024, the filings show a transaction worth €289k in Augmedix, Inc. The last insider purchase was made public on 27 November 2023, 1,056 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.